Tag: travel vaccines market trends

  • Key Drivers and Opportunities in the Travel Vaccines Market: Insights into Trends and Growth

    Key Drivers and Opportunities in the Travel Vaccines Market: Insights into Trends and Growth

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Long-Term Growth Rate is Expected for the Travel Vaccines Market Between 2025 and 2034?

    The travel vaccines market has been expanding significantly. It is projected to grow from $4.73 billion in 2024 to $5.14 billion in 2025 at a CAGR of 8.6%. The growth has been driven by increasing international travel, government initiatives for travel health, the globalization of infectious diseases, growing awareness among travelers, and the expansion of the travel and tourism industry.

    The travel vaccines market size is forecasted to grow substantially, reaching $7.49 billion in 2029 at a CAGR of 9.9%. Factors driving this expansion include increased business travel, emerging infectious disease threats, government regulations and travel entry requirements, rising demand for exotic travel destinations, and partnerships between governments and pharmaceutical companies. Key trends include tailored vaccination strategies, expansion into non-endemic regions, adoption of digital health technologies, regulatory backing and streamlined approvals, and continuous innovation.

    Which Major Market Drivers Are Expected to Boost the Market’s Growth Potential?

    The surge in travel and tourism is expected to fuel the growth of the travel vaccine market going forward. Travel and tourism refer to the movement of people or goods between different geographic locations, including transportation modes such as trains, boats, airplanes, and other means. Travel vaccines are crucial for keeping tourists and travelers safe and healthy while abroad. For instance, in January 2023, the United Nations World Tourism Organization (UNWTO), a Spain-based intergovernmental organization promoting tourism, reported that over 900 million tourists traveled internationally in 2022, doubling the figure from 2021 and still 63% higher than pre-pandemic levels. Therefore, the increase in travel and tourism is driving the growth of the travel vaccine market.

    Request Your Free Travel Vaccines Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

    What Are the Key Firms That Are Driving Transformation in the Travel Vaccines Market?

    Major companies operating in the travel vaccines market include:

    • Pfizer Inc.

    • Johnson and Johnson

    • Merck & Co. Inc.

    • Sanofi SA

    • GlaxoSmithKline plc

    What Current Trends in the Travel Vaccines Market Should Industry Players Pay Attention To?

    Product innovation is an emerging trend gaining traction in the travel vaccine market. Leading companies in this sector are focused on developing cutting-edge vaccines to maintain their market presence. For example, in August 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical firm, received approval from the Indonesia National Agency for Drug and Food Control for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), designed to prevent dengue illness caused by any serotype in individuals aged 6 to 45. Regardless of prior exposure to the disease, QDENGA demonstrated sustained protection against dengue illness and hospitalization for three years post-immunization.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

    What Are the Core Categories and Segments in the Travel Vaccines Market Driving Demand and Growth?

    The travel vaccines market covered in this report is segmented –

    1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

    2) By Composition: Mono Vaccines, Combination Vaccines

    3) By Booking Channel: Online Booking, In-Person Booking

    4) By Application: Domestic Travel, Outbound Travel

    Subsegments:

    1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

    2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

    3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

    4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

    5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

    6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

    7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

    8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

    9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

    What Regions Are Driving Expansion in the Travel Vaccines Market?

    North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Is the Travel Vaccines Market Categorized and Defined in the Industry?

    Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations.

    Browse Through More Similar Reports By The Business Research Company:

    Digital Signature Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/digital-signature-global-market-report

    Insurtech Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/insurtech-global-market-report

    Fingerprint Sensor Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/fingerprint-sensor-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Drivers and Opportunities in the Travel Vaccines Market: Insights into Trends and Growth

    Key Drivers and Opportunities in the Travel Vaccines Market: Insights into Trends and Growth

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Long-Term Growth Rate is Expected for the Travel Vaccines Market Between 2025 and 2034?

    The travel vaccines market has been expanding significantly. It is projected to grow from $4.73 billion in 2024 to $5.14 billion in 2025 at a CAGR of 8.6%. The growth has been driven by increasing international travel, government initiatives for travel health, the globalization of infectious diseases, growing awareness among travelers, and the expansion of the travel and tourism industry.

    The travel vaccines market size is forecasted to grow substantially, reaching $7.49 billion in 2029 at a CAGR of 9.9%. Factors driving this expansion include increased business travel, emerging infectious disease threats, government regulations and travel entry requirements, rising demand for exotic travel destinations, and partnerships between governments and pharmaceutical companies. Key trends include tailored vaccination strategies, expansion into non-endemic regions, adoption of digital health technologies, regulatory backing and streamlined approvals, and continuous innovation.

    Which Major Market Drivers Are Expected to Boost the Market’s Growth Potential?

    The surge in travel and tourism is expected to fuel the growth of the travel vaccine market going forward. Travel and tourism refer to the movement of people or goods between different geographic locations, including transportation modes such as trains, boats, airplanes, and other means. Travel vaccines are crucial for keeping tourists and travelers safe and healthy while abroad. For instance, in January 2023, the United Nations World Tourism Organization (UNWTO), a Spain-based intergovernmental organization promoting tourism, reported that over 900 million tourists traveled internationally in 2022, doubling the figure from 2021 and still 63% higher than pre-pandemic levels. Therefore, the increase in travel and tourism is driving the growth of the travel vaccine market.

    Request Your Free Travel Vaccines Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

    What Are the Key Firms That Are Driving Transformation in the Travel Vaccines Market?

    Major companies operating in the travel vaccines market include:

    • Pfizer Inc._x000D_

    • Johnson and Johnson_x000D_

    • Merck & Co. Inc._x000D_

    • Sanofi SA_x000D_

    • GlaxoSmithKline plc_x000D_

    What Current Trends in the Travel Vaccines Market Should Industry Players Pay Attention To?

    Product innovation is an emerging trend gaining traction in the travel vaccine market. Leading companies in this sector are focused on developing cutting-edge vaccines to maintain their market presence. For example, in August 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical firm, received approval from the Indonesia National Agency for Drug and Food Control for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), designed to prevent dengue illness caused by any serotype in individuals aged 6 to 45. Regardless of prior exposure to the disease, QDENGA demonstrated sustained protection against dengue illness and hospitalization for three years post-immunization.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

    What Are the Core Categories and Segments in the Travel Vaccines Market Driving Demand and Growth?

    The travel vaccines market covered in this report is segmented –

    1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

    2) By Composition: Mono Vaccines, Combination Vaccines

    3) By Booking Channel: Online Booking, In-Person Booking

    4) By Application: Domestic Travel, Outbound Travel

    Subsegments:

    1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

    2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

    3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

    4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

    5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

    6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

    7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

    8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

    9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

    What Regions Are Driving Expansion in the Travel Vaccines Market?

    North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Is the Travel Vaccines Market Categorized and Defined in the Industry?

    Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations.

    Browse Through More Similar Reports By The Business Research Company:

    Digital Signature Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/digital-signature-global-market-report

    Insurtech Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/insurtech-global-market-report

    Fingerprint Sensor Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/fingerprint-sensor-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Drivers and Opportunities in the Travel Vaccines Market: Insights into Trends and Growth

    Key Drivers and Opportunities in the Travel Vaccines Market: Insights into Trends and Growth

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Long-Term Growth Rate is Expected for the Travel Vaccines Market Between 2025 and 2034?

    The travel vaccines market has been expanding significantly. It is projected to grow from $4.73 billion in 2024 to $5.14 billion in 2025 at a CAGR of 8.6%. The growth has been driven by increasing international travel, government initiatives for travel health, the globalization of infectious diseases, growing awareness among travelers, and the expansion of the travel and tourism industry.

    The travel vaccines market size is forecasted to grow substantially, reaching $7.49 billion in 2029 at a CAGR of 9.9%. Factors driving this expansion include increased business travel, emerging infectious disease threats, government regulations and travel entry requirements, rising demand for exotic travel destinations, and partnerships between governments and pharmaceutical companies. Key trends include tailored vaccination strategies, expansion into non-endemic regions, adoption of digital health technologies, regulatory backing and streamlined approvals, and continuous innovation.

    Which Major Market Drivers Are Expected to Boost the Market’s Growth Potential?

    The surge in travel and tourism is expected to fuel the growth of the travel vaccine market going forward. Travel and tourism refer to the movement of people or goods between different geographic locations, including transportation modes such as trains, boats, airplanes, and other means. Travel vaccines are crucial for keeping tourists and travelers safe and healthy while abroad. For instance, in January 2023, the United Nations World Tourism Organization (UNWTO), a Spain-based intergovernmental organization promoting tourism, reported that over 900 million tourists traveled internationally in 2022, doubling the figure from 2021 and still 63% higher than pre-pandemic levels. Therefore, the increase in travel and tourism is driving the growth of the travel vaccine market.

    Request Your Free Travel Vaccines Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

    What Are the Key Firms That Are Driving Transformation in the Travel Vaccines Market?

    Major companies operating in the travel vaccines market include:

    • Pfizer Inc._x000D_

    • Johnson and Johnson_x000D_

    • Merck & Co. Inc._x000D_

    • Sanofi SA_x000D_

    • GlaxoSmithKline plc_x000D_

    What Current Trends in the Travel Vaccines Market Should Industry Players Pay Attention To?

    Product innovation is an emerging trend gaining traction in the travel vaccine market. Leading companies in this sector are focused on developing cutting-edge vaccines to maintain their market presence. For example, in August 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical firm, received approval from the Indonesia National Agency for Drug and Food Control for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), designed to prevent dengue illness caused by any serotype in individuals aged 6 to 45. Regardless of prior exposure to the disease, QDENGA demonstrated sustained protection against dengue illness and hospitalization for three years post-immunization.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

    What Are the Core Categories and Segments in the Travel Vaccines Market Driving Demand and Growth?

    The travel vaccines market covered in this report is segmented –

    1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

    2) By Composition: Mono Vaccines, Combination Vaccines

    3) By Booking Channel: Online Booking, In-Person Booking

    4) By Application: Domestic Travel, Outbound Travel

    Subsegments:

    1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

    2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

    3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

    4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

    5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

    6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

    7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

    8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

    9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

    What Regions Are Driving Expansion in the Travel Vaccines Market?

    North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Is the Travel Vaccines Market Categorized and Defined in the Industry?

    Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations.

    Browse Through More Similar Reports By The Business Research Company:

    Digital Signature Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/digital-signature-global-market-report

    Insurtech Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/insurtech-global-market-report

    Fingerprint Sensor Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/fingerprint-sensor-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Understanding the Travel Vaccines Market’s Growth Prospects from 2024 to 2033

    Understanding the Travel Vaccines Market’s Growth Prospects from 2024 to 2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Forecast: What is the Projected Growth Rate for the Travel Vaccines Market?

    In recent times, there’s been significant growth in the travel vaccines market. The value of this market is projected to rise from $4.41 billion in 2023 to $4.79 billion in 2024, displaying a compound annual growth rate (CAGR) of 8.7%. This previous growth can be ascribed to factors such as heightened international travel, government health initiatives for travelers, the globalization of diseases, rising health-consciousness among travelers, and the expansion of the travel and tourism industry.

    The market for travel vaccines is poised for significant expansion in the coming years, with predictions indicating a rise to $6.79 billion by 2028, boasting a compound annual growth rate (CAGR) of 9.1%. The upward trajectory during the forecast period can be credited to factors such as the growing occurrence of business trips, the emergence of new infectious diseases, government travel protocols, increased interest in unique holiday locations, and partnership between government bodies and pharmaceutical industries. The forecast period also expects trends like personalized vaccine approaches, market distribution to non-endemic areas, implementation of digital health tech, regulatory backing and effortless approvals, along with innovation in the sector.

    Claim Your Free Sample of the Global Travel Vaccines Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

    What Are the Main Drivers Behind the Growth of the travel vaccines Market?

    The rise in travel and tourism activities is predicted to boost the expansion of the travel vaccine market in the future. Travel and tourism involves the transit of individuals or objects using various modes of transport such as trains, boats, planes, and other vehicles across diverse distant geographical zones. Travel vaccines serve a crucial role for tourists and travelers by ensuring their safety and health as they journey overseas. For example, data obtained from the United Nations World Tourism Organization (UNWTO), a Spain-based agency focusing on tourism promotion, indicated that over 900 million tourists travelled abroad in 2022. This figure was double that of 2021 and 63% higher than the numbers recorded prior to the pandemic outbreak. Hence, the escalation in travel and tourism activities is contributing to the upward trajectory of the travel vaccine market.

    What Are the Primary Segments of the Travel Vaccines Market?

    1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

    2) By Composition: Mono Vaccines, Combination Vaccines

    3) By Booking Channel: Online Booking, In-Person Booking

    4) By Application: Domestic Travel, Outbound Travel

    Which Trends Are Revolutionizing the Travel Vaccines Market?

    The adoption of product innovation is a rising trend observed in the travel vaccine market. Dominant companies in this market are creating inventive vaccines in order to enhance their market standing. To illustrate, Takeda Pharmaceutical Company Limited, a pharmaceutical firm based in Japan, received approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003) in August 2022, sanctioned by the Indonesia National Agency for Drug and Food Control for prevention of dengue fever for individuals aged between six and 45 years. Even for those previously exposed to the disease, QDENGA demonstrated its effectiveness three years post-vaccination, providing substantial protection against dengue sickness and hospitalization.

    Order Now for Fast Delivery of Your Travel Vaccines Market Report!

    https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

    Which Geographical Regions Are Pioneering Growth in the Travel Vaccines Market?

    North America was the largest region in the travel vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Travel Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the travel vaccines market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Travel Vaccines Market Include

    1. Travel Vaccines Market Executive Summary

    2. Travel Vaccines Market Segments

    3. Travel Vaccines Market Size And Template Market Growth Rate

    4. Key Travel Vaccines Market Trends

    5. Major Travel Vaccines Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Travel Vaccines Market

    26. Top Travel Vaccines Companies

    27. Travel Vaccines Market Opportunities And Strategies

    28. Travel Vaccines Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Pediatric Vaccine Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

    Adult Vaccines Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

    DTP Vaccines Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Is The Travel Vaccines Market Expected To Grow Through 2024-2033

    How Is The Travel Vaccines Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Travel Vaccines Global Market Report 2024, the travel vaccines market is expected to show promising growth in the forecast period.

    The travel vaccines market experiences robust expansion, driven by various factors and significant innovations, promising a healthier travel experience for global citizens.

    Riding the Wave: Growth Trends in Travel Vaccines Market

    • Historic Growth: From $4.41 billion in 2023 to $4.79 billion in 2024, marking a 8.7% CAGR.
    • Contributing Factors:
      • Increased international travel.
      • Government initiatives for travel health.
      • Globalization of diseases.
      • Growing traveler awareness.
      • Expansion of travel and tourism industry.

    Anticipating the Surge: Future Projections

    • Forecasted Growth: Expected to reach $6.79 billion in 2028, with a CAGR of 9.1%.
    • Driving Factors:
      • Rising frequency of business travel.
      • Emerging infectious disease threats.
      • Government regulations and entry requirements.
      • Demand for exotic destinations.
      • Collaborations between governments and pharmaceutical companies.
    • Key Trends:
      • Tailored vaccination strategies.
      • Market expansion to non-endemic regions.
      • Adoption of digital health technologies.
      • Regulatory support and streamlined approvals.
      • Innovative developments.

    View More On The Travel Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

    Surge In Travel And Tourism Drives Growth Of The Travel Vaccine Market

    • Impact of Travel and Tourism: Movement of people between remote areas surges, boosting the market.
    • Statistics: In 2022, over 900 million tourists traveled abroad, doubling 2021 figures.
    • Key Players: Pfizer, Johnson & Johnson, Merck & Co., Novartis, Sanofi, AstraZeneca, GlaxoSmithKline, Moderna, BioNTech, among others.

    Takeda’s QDENGA Approval Marks A Milestone In Travel Vaccine Innovation

    • Product Innovation: Takeda gains approval for QDENGA, a Dengue Tetravalent Vaccine, offering overall protection.
    • Impact: Provides protection against dengue sickness and hospitalization.
    • Significance: Reflects the trend of companies developing innovative vaccines.

    Bavarian Nordic Bolsters Travel Vaccine Portfolio With Acquisition Of Emergent Biosolutions’ Assets

    • Acquisition: Bavarian Nordic acquires Emergent Biosolutions’ travel vaccine portfolio.
    • Assets: Includes vaccines for typhoid fever, cholera, and a Phase 3 candidate for Chikungunya virus.
    • Expansion: Gains US and EU commercial operations, specialized salesforce, and R&D facilities.

    Segmentation Insights: Understanding Market Dynamics

    • By Disease: Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles, Rabies, Meningococcal, Others.
    • By Composition: Mono Vaccines, Combination Vaccines.
    • By Booking Channel: Online Booking, In-Person Booking.
    • By Application: Domestic Travel, Outbound Travel.

    Regional Dynamics: Shaping Market Landscape

    • North America: Largest market in 2023.
    • Asia-Pacific: Expected to witness fastest growth in the forecast period.

    Conclusion: Navigating the Future of Travel Vaccines

    The travel vaccines market is poised for substantial growth, fueled by increasing travel and tourism, coupled with innovations in vaccine development. With companies focusing on tailored strategies and expanding their portfolios, travelers can anticipate a safer and healthier journey ahead. As the world continues to adapt to evolving disease landscapes, the travel vaccines market stands as a crucial pillar in safeguarding global health during expeditions across borders.

    Request A Sample Of The Global Travel Vaccines Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=11918&type=smp